Comment on Umapathysivam et al. Euglycemic Ketoacidosis in Two Patients Without Diabetes After Introduction of Sodium-Glucose Cotransporter 2 Inhibitor for Heart Failure With Reduced Ejection Fraction. Diabetes Care 2024;47:140-143
Diabetes Care
.
2024 Apr 1;47(4):e35.
doi: 10.2337/dc24-0094.
Authors
Foussard Ninon
1
,
Larroumet Alice
1
,
Barbet-Massin Marie-Amélie
1
,
Blanco Laurence
1
,
Mohammedi Kamel
1
,
Couffinhal Thierry
1
,
Fawaz Sami
1
,
Pucheu Yann
1
,
Rigalleau Vincent
1
Affiliation
1
Departments of Endocrinology-Diabetology-Nutrition and Cardiology, CHU Bordeaux, Bordeaux, France.
PMID:
38527115
DOI:
10.2337/dc24-0094
No abstract available
Publication types
Case Reports
MeSH terms
Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / drug therapy
Diabetic Ketoacidosis* / drug therapy
Glucose
Heart Failure* / drug therapy
Humans
Sodium
Stroke Volume
Substances
Glucose
Sodium